nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Parkinson's disease	0.933	1	CbGaD
Dihydrocodeine—OPRM1—telencephalic ventricle—Parkinson's disease	0.0061	0.262	CbGeAlD
Dihydrocodeine—OPRM1—nerve—Parkinson's disease	0.00385	0.165	CbGeAlD
Dihydrocodeine—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.00203	0.0611	CbGpPWpGaD
Dihydrocodeine—OPRM1—brainstem—Parkinson's disease	0.00165	0.0708	CbGeAlD
Dihydrocodeine—Galantamine—CHRNA4—Parkinson's disease	0.00162	0.164	CrCbGaD
Dihydrocodeine—OPRM1—forebrain—Parkinson's disease	0.00159	0.0683	CbGeAlD
Dihydrocodeine—OPRM1—G-protein activation—PDYN—Parkinson's disease	0.00145	0.0435	CbGpPWpGaD
Dihydrocodeine—Dextromethorphan—CHRNA4—Parkinson's disease	0.00121	0.123	CrCbGaD
Dihydrocodeine—CYP2D6—hindbrain—Parkinson's disease	0.00116	0.0495	CbGeAlD
Dihydrocodeine—OPRM1—midbrain—Parkinson's disease	0.00105	0.0451	CbGeAlD
Dihydrocodeine—OPRM1—spinal cord—Parkinson's disease	0.00103	0.044	CbGeAlD
Dihydrocodeine—OPRM1—Opioid Signalling—PPP1R1B—Parkinson's disease	0.000931	0.028	CbGpPWpGaD
Dihydrocodeine—OPRM1—head—Parkinson's disease	0.000913	0.0391	CbGeAlD
Dihydrocodeine—OPRM1—nervous system—Parkinson's disease	0.000865	0.0371	CbGeAlD
Dihydrocodeine—Oxymorphone—CYP2D6—Parkinson's disease	0.000833	0.0844	CrCbGaD
Dihydrocodeine—OPRM1—central nervous system—Parkinson's disease	0.000833	0.0357	CbGeAlD
Dihydrocodeine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.0008	0.0241	CbGpPWpGaD
Dihydrocodeine—Ethylmorphine—CYP2D6—Parkinson's disease	0.000797	0.0807	CrCbGaD
Dihydrocodeine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000794	0.0239	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.000732	0.022	CbGpPWpGaD
Dihydrocodeine—Hydrocodone—CYP2D6—Parkinson's disease	0.000728	0.0738	CrCbGaD
Dihydrocodeine—Oxycodone—CYP2D6—Parkinson's disease	0.000665	0.0674	CrCbGaD
Dihydrocodeine—CYP2D6—brainstem—Parkinson's disease	0.000662	0.0284	CbGeAlD
Dihydrocodeine—OPRM1—brain—Parkinson's disease	0.000661	0.0283	CbGeAlD
Dihydrocodeine—CYP2D6—forebrain—Parkinson's disease	0.000639	0.0274	CbGeAlD
Dihydrocodeine—Codeine—CYP2D6—Parkinson's disease	0.000634	0.0643	CrCbGaD
Dihydrocodeine—Hydromorphone—CYP2D6—Parkinson's disease	0.000604	0.0612	CrCbGaD
Dihydrocodeine—OPRM1—Opioid Signalling—PDYN—Parkinson's disease	0.0006	0.0181	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000588	0.0177	CbGpPWpGaD
Dihydrocodeine—Dextromethorphan—CYP2E1—Parkinson's disease	0.000587	0.0595	CrCbGaD
Dihydrocodeine—Galantamine—CYP2D6—Parkinson's disease	0.000576	0.0583	CrCbGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—VIM—Parkinson's disease	0.000567	0.0171	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.000565	0.017	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.000523	0.0157	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.000515	0.0155	CbGpPWpGaD
Dihydrocodeine—Morphine—CYP2D6—Parkinson's disease	0.000513	0.052	CrCbGaD
Dihydrocodeine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000492	0.0148	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000473	0.0142	CbGpPWpGaD
Dihydrocodeine—Dextromethorphan—CYP2D6—Parkinson's disease	0.000431	0.0437	CrCbGaD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.000421	0.0127	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000403	0.0121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000385	0.0116	CbGpPWpGaD
Dihydrocodeine—Morphine—ABCB1—Parkinson's disease	0.000367	0.0371	CrCbGaD
Dihydrocodeine—CYP2D6—head—Parkinson's disease	0.000366	0.0157	CbGeAlD
Dihydrocodeine—OPRM1—Opioid Signalling—ADRBK1—Parkinson's disease	0.00036	0.0108	CbGpPWpGaD
Dihydrocodeine—CYP3A4—nervous system—Parkinson's disease	0.000353	0.0151	CbGeAlD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.000352	0.0106	CbGpPWpGaD
Dihydrocodeine—CYP2D6—nervous system—Parkinson's disease	0.000347	0.0149	CbGeAlD
Dihydrocodeine—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.000346	0.0104	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000345	0.0104	CbGpPWpGaD
Dihydrocodeine—CYP3A4—central nervous system—Parkinson's disease	0.000339	0.0145	CbGeAlD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000338	0.0102	CbGpPWpGaD
Dihydrocodeine—CYP2D6—central nervous system—Parkinson's disease	0.000334	0.0143	CbGeAlD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.000332	0.00998	CbGpPWpGaD
Dihydrocodeine—CYP2D6—cerebellum—Parkinson's disease	0.000326	0.014	CbGeAlD
Dihydrocodeine—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.000322	0.00968	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000309	0.00931	CbGpPWpGaD
Dihydrocodeine—Dextromethorphan—ABCB1—Parkinson's disease	0.000308	0.0312	CrCbGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.000303	0.00913	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000301	0.00905	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000295	0.00888	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00029	0.00873	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000289	0.00869	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000286	0.0086	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00028	0.00843	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—PENK—Parkinson's disease	0.00028	0.00842	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000265	0.00798	CbGpPWpGaD
Dihydrocodeine—CYP2D6—brain—Parkinson's disease	0.000265	0.0114	CbGeAlD
Dihydrocodeine—OPRM1—GPCR ligand binding—GPR37—Parkinson's disease	0.000263	0.00791	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000256	0.0077	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000244	0.00733	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000243	0.00731	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000228	0.00686	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000223	0.00669	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00021	0.00633	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.000205	0.00616	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000204	0.00615	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000204	0.00612	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000202	0.00607	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000188	0.00565	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.000179	0.00538	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000176	0.00528	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000172	0.00519	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—PENK—Parkinson's disease	0.000169	0.0051	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000166	0.00498	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000165	0.00497	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000164	0.00494	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—DRD3—Parkinson's disease	0.000164	0.00494	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000163	0.0049	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000161	0.00484	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000159	0.00479	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000157	0.00473	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.000155	0.00466	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000152	0.00458	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000149	0.00447	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000149	0.00447	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000146	0.00439	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000145	0.00437	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000144	0.00434	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.000144	0.00433	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000143	0.00431	CbGpPWpGaD
Dihydrocodeine—OPRM1—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.000141	0.00424	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00014	0.0042	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000138	0.00415	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000138	0.00415	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000137	0.00414	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000136	0.0041	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000135	0.00406	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.000135	0.00406	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000135	0.00406	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000134	0.00402	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL1B—Parkinson's disease	0.000133	0.004	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000132	0.00397	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000131	0.00393	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000129	0.00389	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000123	0.00371	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000123	0.00369	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.000122	0.00366	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000118	0.00356	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000118	0.00355	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000118	0.00355	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000113	0.00339	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000108	0.00326	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000106	0.0032	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.000105	0.00315	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.000103	0.00309	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.000102	0.00308	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000101	0.00304	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—DRD3—Parkinson's disease	9.94e-05	0.00299	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	9.65e-05	0.0029	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	9.62e-05	0.00289	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	9.58e-05	0.00288	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	9.5e-05	0.00286	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	9.45e-05	0.00284	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	9.37e-05	0.00282	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	9.17e-05	0.00276	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	8.99e-05	0.0027	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	8.99e-05	0.0027	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.91e-05	0.00268	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	8.8e-05	0.00265	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	8.76e-05	0.00263	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	8.7e-05	0.00262	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.68e-05	0.00261	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	8.46e-05	0.00255	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	8.27e-05	0.00249	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	8.14e-05	0.00245	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	7.97e-05	0.0024	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	7.97e-05	0.0024	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	7.95e-05	0.00239	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	7.78e-05	0.00234	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	7.39e-05	0.00222	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.29e-05	0.00219	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	7.29e-05	0.00219	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.26e-05	0.00218	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.24e-05	0.00218	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	7.2e-05	0.00217	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.19e-05	0.00216	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.16e-05	0.00215	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	6.92e-05	0.00208	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	6.67e-05	0.00201	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	6.58e-05	0.00198	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	6.37e-05	0.00192	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	6.3e-05	0.00189	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.29e-05	0.00189	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	6.29e-05	0.00189	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.2e-05	0.00187	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	6.04e-05	0.00182	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	6.01e-05	0.00181	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	5.92e-05	0.00178	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	5.8e-05	0.00175	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.75e-05	0.00173	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.67e-05	0.00171	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	5.62e-05	0.00169	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	5.46e-05	0.00164	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	5.42e-05	0.00163	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	5.37e-05	0.00162	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	5.27e-05	0.00158	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.25e-05	0.00158	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAG—Parkinson's disease	5.14e-05	0.00155	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PENK—Parkinson's disease	5.14e-05	0.00155	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	5.1e-05	0.00153	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	5.08e-05	0.00153	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	5.08e-05	0.00153	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.77e-05	0.00143	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	4.76e-05	0.00143	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.75e-05	0.00143	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.73e-05	0.00142	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ND3—Parkinson's disease	4.73e-05	0.00142	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.73e-05	0.00142	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.7e-05	0.00141	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	4.7e-05	0.00141	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.68e-05	0.00141	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	4.61e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	4.61e-05	0.00139	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.45e-05	0.00134	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.45e-05	0.00134	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	4.42e-05	0.00133	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	4.37e-05	0.00131	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.36e-05	0.00131	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.3e-05	0.00129	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.21e-05	0.00127	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	4.07e-05	0.00122	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.02e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	3.83e-05	0.00115	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	3.71e-05	0.00112	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	3.69e-05	0.00111	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.58e-05	0.00108	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.58e-05	0.00108	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.58e-05	0.00108	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	3.56e-05	0.00107	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INSR—Parkinson's disease	3.43e-05	0.00103	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGB—Parkinson's disease	3.24e-05	0.000974	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	3.23e-05	0.000972	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	3.22e-05	0.000969	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	3.17e-05	0.000955	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	3.11e-05	0.000936	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.09e-05	0.00093	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.09e-05	0.00093	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	3.01e-05	0.000907	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.91e-05	0.000874	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—OMD—Parkinson's disease	2.91e-05	0.000874	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	2.81e-05	0.000847	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.76e-05	0.000829	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	2.73e-05	0.00082	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	2.73e-05	0.00082	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.63e-05	0.000791	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.63e-05	0.000791	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.48e-05	0.000747	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.34e-05	0.000705	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.34e-05	0.000705	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.34e-05	0.000705	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	2.28e-05	0.000687	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.24e-05	0.000673	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.21e-05	0.000666	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	2.21e-05	0.000664	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	2.18e-05	0.000656	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NGF—Parkinson's disease	2.01e-05	0.000603	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	1.91e-05	0.000574	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOE—Parkinson's disease	1.78e-05	0.000534	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.72e-05	0.000517	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.62e-05	0.000489	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.62e-05	0.000486	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—INS—Parkinson's disease	1.52e-05	0.000456	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.5e-05	0.000453	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.49e-05	0.000448	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TH—Parkinson's disease	1.47e-05	0.000441	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.46e-05	0.00044	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.45e-05	0.000435	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.41e-05	0.000424	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.25e-05	0.000375	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.24e-05	0.000373	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.24e-05	0.000372	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.22e-05	0.000368	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.17e-05	0.000353	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.14e-05	0.000343	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.13e-05	0.00034	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.12e-05	0.000337	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.09e-05	0.000329	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.08e-05	0.000324	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.06e-05	0.000318	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.04e-05	0.000312	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.01e-05	0.000303	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.84e-06	0.000296	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.73e-06	0.000293	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TH—Parkinson's disease	9.59e-06	0.000288	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOE—Parkinson's disease	9.38e-06	0.000282	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.21e-06	0.000277	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COMT—Parkinson's disease	8.15e-06	0.000245	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.11e-06	0.000244	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.1e-06	0.000244	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—INS—Parkinson's disease	8.02e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8e-06	0.000241	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.68e-06	0.000231	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.46e-06	0.000224	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.14e-06	0.000215	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—Parkinson's disease	6.63e-06	0.000199	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.59e-06	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOE—Parkinson's disease	6.14e-06	0.000185	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—INS—Parkinson's disease	5.24e-06	0.000158	CbGpPWpGaD
